WorldCat Identities

Batki, Steven L.

Overview
Works: 15 works in 25 publications in 1 language and 1,395 library holdings
Genres: Technical reports 
Roles: Author, Other
Classifications: RC607.A26, 362.196979200973
Publication Timeline
.
Most widely held works by Steven L Batki
Substance abuse treatment for persons with HIV/AIDS( )

1 edition published in 2000 in English and held by 318 WorldCat member libraries worldwide

The TIP is organized into ten chapters, the first of which provides an introduction to HIV/AIDS, including the origin, life cycle, and progression of the disease. The second part of Chapter 1 provides an overview of the changes in epidemiology since 1995 when the first edition of this TIP was published. Epidemiological data from the Centers for Disease Control and Prevention (CDC) are summarized, and readers are provided with an overview of the pandemic in the regions of the United States, the current trends and populations most affected by the disease, and a discussion of special populations. Chapter 2, which is targeted to medical personnel, discusses the medical assessment and treatment of HIV/AIDS, including adherence to treatment, barriers to care, treatment and testing, pharmacology, and prophylaxis against opportunistic infections. Chapter 3, which is aimed at mental health workers, explores the mental health treatment of clients with substance abuse problems and HIV/AIDS and discusses common mental disorders, assessment and diagnosis, pharmacology, counseling, and staff issues. Chapter 4 presents issues concerning HIV prevention. These issues include assessing clients for risk, risk-reduction counseling, sexual risk reduction, prenatal and perinatal prevention, transmission of resistant strains of HIV, syringe sharing, rapid HIV testing, and infection control issues for programs. Chapter 5 discusses integrating treatment services, as well as the importance of linkages between substance abuse treatment programs and other providers. Chapter 6 provides information about case management and finding resources for HIV-infected substance abusers, including resources for substance abuse treatment, mental health, medical care, and income and other financial concerns for clients. Chapter 7 examines counseling issues, including staff training and attitudes, screening, and issues specific to the substance-abusing client with HIV/AIDS. Chapter 8 explores ethical issues, and Chapter 9 discusses legal issues and provides basic information about Federal laws regarding discrimination and confidentiality. Chapter 10, geared toward program administrators, presents information about funding sources and grantwriting. In light of the volumes of information available about HIV/AIDS, this TIP is not intended to be exhaustive. A wide array of resources is provided for those who wish to find more information on topics of interest. The appendixes in this TIP provide additional information on several topics and include the 1993 Revised Classification System for HIV and AIDS, Federal and State codes of ethics, AIDS-related Web sites, and a list of State and Territorial health agencies and AIDS hotlines
Medication-assisted treatment for opioid addiction in opioid treatment programs by Steven L Batki( )

1 edition published in 2005 in English and held by 293 WorldCat member libraries worldwide

Treatment for HIV-infected alcohol and other drug abusers by Peter A Selwyn( Book )

3 editions published in 1995 in English and held by 271 WorldCat member libraries worldwide

Substance abuse treatment for persons with HIV/AIDS( Book )

3 editions published between 2000 and 2003 in English and held by 261 WorldCat member libraries worldwide

The TIP is organized into ten chapters, the first of which provides an introduction to HIV/AIDS, including the origin, life cycle, and progression of the disease. The second part of Chapter 1 provides an overview of the changes in epidemiology since 1995 when the first edition of this TIP was published. Epidemiological data from the Centers for Disease Control and Prevention (CDC) are summarized, and readers are provided with an overview of the pandemic in the regions of the United States, the current trends and populations most affected by the disease, and a discussion of special populations. Chapter 2, which is targeted to medical personnel, discusses the medical assessment and treatment of HIV/AIDS, including adherence to treatment, barriers to care, treatment and testing, pharmacology, and prophylaxis against opportunistic infections. Chapter 3, which is aimed at mental health workers, explores the mental health treatment of clients with substance abuse problems and HIV/AIDS and discusses common mental disorders, assessment and diagnosis, pharmacology, counseling, and staff issues. Chapter 4 presents issues concerning HIV prevention. These issues include assessing clients for risk, risk-reduction counseling, sexual risk reduction, prenatal and perinatal prevention, transmission of resistant strains of HIV, syringe sharing, rapid HIV testing, and infection control issues for programs. Chapter 5 discusses integrating treatment services, as well as the importance of linkages between substance abuse treatment programs and other providers. Chapter 6 provides information about case management and finding resources for HIV-infected substance abusers, including resources for substance abuse treatment, mental health, medical care, and income and other financial concerns for clients. Chapter 7 examines counseling issues, including staff training and attitudes, screening, and issues specific to the substance-abusing client with HIV/AIDS. Chapter 8 explores ethical issues, and Chapter 9 discusses legal issues and provides basic information about Federal laws regarding discrimination and confidentiality. Chapter 10, geared toward program administrators, presents information about funding sources and grantwriting. In light of the volumes of information available about HIV/AIDS, this TIP is not intended to be exhaustive. A wide array of resources is provided for those who wish to find more information on topics of interest. The appendixes in this TIP provide additional information on several topics and include the 1993 Revised Classification System for HIV and AIDS, Federal and State codes of ethics, AIDS-related Web sites, and a list of State and Territorial health agencies and AIDS hotlines
Medication-assisted treatment for opioid addiction in opioid treatment programs by Steven L Batki( )

1 edition published in 2012 in English and held by 202 WorldCat member libraries worldwide

Substance abuse treatment for persons with HIV/AIDS by Steven L Batki( Book )

3 editions published between 2002 and 2008 in English and held by 14 WorldCat member libraries worldwide

Medication-assisted treatment for opioid addiction in opioid treatment programs( Book )

2 editions published between 2008 and 2010 in English and held by 11 WorldCat member libraries worldwide

Substance abuse treatment for persons with HIV/AIDS( Book )

2 editions published between 2003 and 2006 in English and held by 9 WorldCat member libraries worldwide

Medication-assisted treatment for opioid addiction in opioid treatment programs by Steven L Batki( )

2 editions published in 2008 in English and held by 7 WorldCat member libraries worldwide

Substance abuse treatment for persons with HIV/AIDS( Book )

2 editions published in 2003 in English and held by 3 WorldCat member libraries worldwide

Pharmacological Treatment of Schizophrenia and Co-Occurring Substance Use Disorders by David A Smelson( )

1 edition published in 2008 in English and held by 2 WorldCat member libraries worldwide

A controlled trial of methadone treatment combined with directly observed isoniazid for tuberculosis prevention in injection drug users by Steven L Batki( )

1 edition published in 2002 in Undetermined and held by 1 WorldCat member library worldwide

Substance abuse is associated with high risk for tuberculosis (TB) and poor adherence to medication regimens. This study compared completion rates for isoniazid (INH) preventive therapy for injection drug users (IDUs) randomly assigned to methadone treatment combined with directly observed preventive treatment (DOPT) versus those assigned to routine TB clinic referral without methadone treatment. One hundred and eleven opioid-dependent patients with latent TB were assigned to one of three 6-month treatment conditions: standard methadone treatment including substance abuse counseling combined with daily INH DOPT (n=37); minimal methadone treatment without counseling, also combined with daily INH DOPT (n=35); or routine care referral to TB clinic for monthly INH supplies without DOPT and without methadone treatment (n=39). INH completion rates were 77.1% for minimal methadone and 59.5% for standard methadone, as compared with only 13.5% for routine care (P<0.0001). Mean duration of INH treatment retention was 5.7, 5.0 and 1.6 months, respectively (P<0.0001). TB incidence at 4-year follow-up was 0 of 54 subjects who completed preventive therapy versus 2 of 57 who failed to complete. One of these two had been assigned to routine care, and the other to minimal methadone. In conclusion, INH retention time and completion rates were significantly improved by methadone treatment combined with observed INH, whether or not substance abuse counseling was provided. The results of this study indicate that methadone treatment offers clear public health benefits when it is used to deliver preventive medical services
Medication - assisted treatment for opioid addiction in opioid treatment programs : a treatment improvement protocol TIP 43( Book )

1 edition published in 2005 in English and held by 1 WorldCat member library worldwide

Substance abuse treatment for persons with HIV, AIDS( Book )

1 edition published in 2000 in English and held by 1 WorldCat member library worldwide

Treatment for HIV-infected alcohol and other drug abusers by Peter A Selwyn( Book )

1 edition published in 1995 in English and held by 1 WorldCat member library worldwide

 
moreShow More Titles
fewerShow Fewer Titles
Audience Level
0
Audience Level
1
  Kids General Special  
Audience level: 0.42 (from 0.23 for Substance ... to 0.99 for A controll ...)

Languages
English (24)